About PregTrade
Company Overview
PregTrade is a financial entity registered in the United States, with a registered address at 198-100 W 14TH ST, New York, NY 10011. The company was founded on August 17, 2022, indicating a relatively recent entry into the financial services industry.
As a US-registered entity, PregTrade operates under the legal framework of the state of New York. However, the company does not hold any known regulatory licences from major financial authorities, which is a significant factor for potential clients to consider.
Regulatory Status
Our records indicate that PregTrade is not regulated by any financial supervisory body. The absence of regulatory oversight is a critical point, as it means the company is not subject to standard requirements for capital adequacy, client fund segregation, or dispute resolution mechanisms.
For traders and investors, the lack of regulation introduces elevated counterparty risk. Without a regulatory safety net, clients have limited recourse in the event of disputes or financial difficulties.
Public Information Availability
Independent public information about PregTrade is extremely limited. There are no user reviews, industry database entries, or web search results that provide further insight into the company's operations, services, or reputation.
This information vacuum makes it challenging to assess the credibility and reliability of PregTrade. Prospective clients should exercise caution when dealing with entities that have minimal publicly available track records.
Conclusion
PregTrade remains an opaque entity with a short operating history and no regulatory oversight. The lack of public information amplifies the risks associated with any potential engagement.
Given these factors, PregTrade should be approached with extreme caution. Traders and investors are strongly advised to seek fully regulated and transparent alternatives for their financial activities.
Overview compiled by FXCanary from regulatory records and public data. full PregTrade review